Medicalsystem Biotechnology Co., Ltd (SHE:300439)
China flag China · Delayed Price · Currency is CNY
10.25
+0.10 (0.99%)
Feb 4, 2026, 3:04 PM CST

SHE:300439 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Cash & Equivalents
630.52728.64958.88806.41666.31328.21
Short-Term Investments
-10.12----
Trading Asset Securities
265.9161.08680.17100.7-
Cash & Short-Term Investments
896.42899.84964.88886.58767.01328.21
Cash Growth
5.12%-6.74%8.83%15.59%133.70%-24.82%
Accounts Receivable
576.9557.16569.92816.36827.94867.47
Other Receivables
12.4515.5636.3275.6945.959.06
Receivables
589.35572.72606.24892.05873.84926.53
Inventory
254.35286.01259.01218.03211.39253.92
Other Current Assets
139.7865.6369.0374.88157.761.4
Total Current Assets
1,8801,8241,8992,0722,0101,570
Property, Plant & Equipment
1,3731,4161,1781,0651,0481,046
Long-Term Investments
172.16190.73160.94162.7184.38256.35
Goodwill
-----13.56
Other Intangible Assets
131.46135.43127.85120.19148.37163.4
Long-Term Deferred Tax Assets
61.7640.7535.5325.5541.1136.01
Long-Term Deferred Charges
30.7739.8234.3418.635.2465.87
Other Long-Term Assets
5.8857.9453.05119.82125.81103.42
Total Assets
3,6553,7053,4893,5843,5933,254
Accounts Payable
359.42369.41333.46374.26331.34277.23
Accrued Expenses
65.92102.97109.57123.02129.15120.02
Short-Term Debt
-30.0250.05217.76340.22782.43
Current Portion of Long-Term Debt
--7.0463.1252.1247.2
Current Portion of Leases
13.115.7912.4816.7518.86-
Current Income Taxes Payable
14.839.6215.9110.815.4116.24
Current Unearned Revenue
52.2163.7888.2775.4537.9356.49
Other Current Liabilities
97.4375.8582.34100.13136.1790.03
Total Current Liabilities
602.92667.44699.13981.31,0611,390
Long-Term Debt
---7.0445.0397.02
Long-Term Leases
31.9437.1123.626.9725.64-
Long-Term Unearned Revenue
27.1717.029.92.329.3917.23
Long-Term Deferred Tax Liabilities
40.5546.2848.4234.9861.1963.27
Other Long-Term Liabilities
4.183.81.4511.62--
Total Liabilities
706.76771.65782.491,0641,2021,567
Common Stock
384.32383.95383383383343
Additional Paid-In Capital
1,1231,1201,1091,1171,117570.16
Retained Earnings
1,4671,4581,2521,035872.85753.39
Treasury Stock
-2.91-5.82----
Comprehensive Income & Other
-15.9-16.94-29.14-24.69-25.59-24.87
Total Common Equity
2,9562,9402,7152,5102,3471,642
Minority Interest
-7.3-6.36-8.249.3843.7245.32
Shareholders' Equity
2,9482,9332,7072,5192,3911,687
Total Liabilities & Equity
3,6553,7053,4893,5843,5933,254
Total Debt
45.0582.9293.17331.64481.87926.66
Net Cash (Debt)
851.37816.92871.71554.94285.14-598.45
Net Cash Growth
8.23%-6.29%57.08%94.62%--
Net Cash Per Share
2.212.122.281.450.76-1.74
Filing Date Shares Outstanding
384.32383.95383.95383383383
Total Common Shares Outstanding
384.32383.95383383383343
Working Capital
1,2771,1571,2001,090948.74180.4
Book Value Per Share
7.697.667.096.556.134.79
Tangible Book Value
2,8242,8042,5872,3902,1991,465
Tangible Book Value Per Share
7.357.306.756.245.744.27
Buildings
-1,085749.23544.4544.18587.92
Machinery
-902.18912.39936.77936.19904.95
Construction In Progress
-11.99160.5189.8141.11114.72
Source: S&P Global Market Intelligence. Standard template. Financial Sources.